Crystalline mycophenolate sodium

Details Crystalline mycophenolate sodium Crystalline mycophenolate sodium

2005-07-20

2008-10-21

Seaman, D. Margaret (Department: 1625)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C544S153000

Reexamination Certificate

active

07439373

ABSTRACT:
Provided are crystalline mycophenolate sodium forms and processes for their preparation.

REFERENCES:
patent: 4452891 (1984-06-01), Kida et al.
patent: 4748173 (1988-05-01), Nelson et al.
patent: 4753935 (1988-06-01), Nelson et al.
patent: 4786637 (1988-11-01), Allison et al.
patent: 4808592 (1989-02-01), Nelson et al.
patent: 4861776 (1989-08-01), Nelson et al.
patent: 4868153 (1989-09-01), Allison et al.
patent: 4948793 (1990-08-01), Allison et al.
patent: 4952579 (1990-08-01), Nelson et al.
patent: 5247083 (1993-09-01), Knox et al.
patent: 5455045 (1995-10-01), Samuels et al.
patent: 5543408 (1996-08-01), Fu et al.
patent: 5545637 (1996-08-01), Fu et al.
patent: 5688529 (1997-11-01), Lidgate et al.
patent: 6333198 (2001-12-01), Edmeades et al.
patent: 6709846 (2004-03-01), Sircar et al.
patent: 2004/0167130 (2004-08-01), Lee et al.
patent: 0 281 713 (1988-09-01), None
patent: 0 963 980 (1999-12-01), None
patent: 1 157 099 (1969-07-01), None
patent: 1 158387 (1969-07-01), None
patent: WO 94/01427 (1994-01-01), None
patent: WO 97/38689 (1997-10-01), None
patent: WO 00/34503 (2000-06-01), None
patent: WO 01/21607 (2001-03-01), None
patent: WO 01/64931 (2001-09-01), None
patent: WO 02/100855 (2002-12-01), None
patent: WO 2004064806 (2004-01-01), None
patent: WO 2004/020426 (2004-03-01), None
patent: WO 2004/064806 (2004-08-01), None
patent: WO 2004/087174 (2004-10-01), None
patent: 68/4959 (1967-11-01), None
Rihs et al., “Metal-Organic Compounds: Sodium Mycophenolate”,Acta Crystallographic2000, C56, pp. 423-433.
Wrigglesworth et al. “Analogues of Capsaicin with Agonist Activity as Novel Analgesic Agents: Structure-Activity Studies”,Journal of Medicinal Chemistry, 1996, pp. 4942-4951, vol. 39, No. 25.
Caira, “Crystalline Polymorphism of Organic Compounds”,Topics in Current Chemistry, 1998, pp. 163-208, vol. 198.
Sadhukhan et al. “Optimization of Mycophenolic Acid Production in Solid State Fermentation Using Response Surface Methodology”,Journal of Industrial Microbiology and Biotechnology, 1999, pp. 33-38, vol. 22, No. 1.
Makara et al. “Nuclear Magnetic Resonance and Molecular Modeling Study on Mcyophenolic Acid: Implications for Binding to Inosine Monophosphate Dehydrogenase”,Journal of Medicinal Chemistry, 1996, pp. 1236-1242, vol. 39, No. 6+.
Abraham, “The Effect Of Mycophenolic Acid On The Growth OfStaphylococcus aureusIn Heart Broth”,Biochem. J., 1945, pp. 398-408, vol. 39, No. 5.
Ando, et al., “Antiviral Activity Of Mycophenolic Acid Studies On Antiviral And Antitumor Antibiotics. IV”,The Journal of Antibiotics, Aug. 19, 1968, pp. 649-652, vol. 21, No. 11.
Bentley, “Bartolomeo Gosio, 1863-1944: An Appreciation”,Advances In Applied Microbiology, 2001, pp. 229-251, vol. 48.
Bentley, “Mycophenolic Acid: A One Hundred Year Odyssey From Antibiotic To Immunosuppressant”,Chem. Rev. 2000, pp. 3801-3825, vol. 100, No. 10.
Guillory, “Polymorphism in Pharmaceutical Solids”,Drugs and the Pharmaceutical Sciences, edited by Brittain, 1999, pp. 184-222, vol. 95. Marcel Dekker, Inc.
Clutterbuck, et al., “The Metabolic Products Of The Penicillium Brevi-Compactum Series”,Studies In The Biochemistry Of Micro-Organisms, 1932, pp. 1441-1458.
Craig, et al., “The Relevance Of The Amorphous State To Pharmaceutical Dosage Forms: Glassy Drugs And Freeze Dried Systems”,International Journal of Pharmaceutics, 1999, pp. 179-207, vol. 179.
Desrosiers, et al., “High Throughput Screening Techniques For Pre-Formulation: Salt Selection And Polymorph Studies”,Acta Cryst., 2002, A58 (Supplement), C9.
Filtenborg, et al., “Simple Screening Method For Molds Producing Intracellular Mycotoxins In Pure Cultures”,Applied and Environmental Microbiology, Feb. 1983, pp. 581-585, vol. 45, No. 2.
Franklin, et al., “The Inhibition Of Nucleic Acid Synthesis By Mycophenolic Acid”,Biochem. J., 1969, pp. 515-524, vol. 113.
Frisvad, et al., “Classification OfTerverticillate penicillaBased On Profiles Of Mycotoxins And Other Secondary Metabolites”,Applied and Environmental Microbiology, 1983, pp. 1301-1310, vol. 46, No. 6.
Gainer, et al., “GLC Of Mycophenolic Acid And Related Compounds”,Journal of Pharmaceutical Sciences, 1970, pp. 1157-1159, vol. 59, No. 8.
Gilliver, “The Inhibitory Action Of Antibiotics On Plant Pathogenic Bacteria And Fungi”,Annals of Botany, N.S., 1946, pp. 271-282, vol. 10, No. 39.
Gosio, “Sur La Reconnaissance De L'Arsenic, Au Moyen De Certaines Moisissures”,Archives Italiennes De Biologie, 1893, pp. 299-305.
Gu, et al., “Grouping Solvents By Statistical Analysis Of Solvent Property Parameters: Implication To Polymorph Screening”,International Journal of Pharmaceutics, 2004, pp. 117-125, vol. 283.
Gu, et al., “Polymorph Screening: Influence Of Solvents On The Rate Of Solvent-Mediated Polymorphic Transformation”,Journal of Pharmaceutical Sciences, 2001, pp. 1878-1890, vol. 90, No. 11.
Hilfiker, et al., “Polymorphism—Integrated Approach From High-Throughput Screening To Crystallization Optimization”,Journal of Thermal Analysis and Calorimetry, 2003, pp. 429-440, vol. 73.
Makara, et al., “Nuclear Magnetic Resonance And Molecular Study On Mycophenolic Acid: Implications For Binding To Monophosphate Dehydrogenase”,Journal of Medicinal Chemistry, 1996, pp. 1236-1242, vol. 39, No. 6.
Noto, et al., “Some Biological Properties Of Mycophenolic Acid”,The Journal of Antibiotics, 1969, pp. 165-169, vol. 22, No. 4.
Nowak, et al., “Mycophenolic Acid Binding To Human Serum Albumin: Characterization And Relation To Pharmacodynamics”,Clinical Chemistry, 1995, pp. 1011-1017, vol. 41, No. 7.
Rihs, et al., “Sodium Mycophenolate”,Acta Crystallographica, 2000, pp. 432-433, vol. C56.
Snyder, et al.,Introduction To Modern Liquid Chromatography, 2ndEd., 1979, pp. 549-572, John Wiley & Sons, Inc.
Sollinger, Hans W., “Mycophenolate Mofetil”,Kidney International, 1995, pp. S-14-S-17, vol. 48, Suppl. 52.
Strobel, et al.,Chemical Instrumentation: A Systematic Approach, 3rdEd., 1989, pp. 391-393, 879-894, 922-925, 953.
Wagner, et al., “Carboxylic Esters”,Synthetic Organic Chemistry, 1953, pp. 479-531.
Wiwattanawongsa, et al., “Determination Of Mycophenolic Acid And Its Phenol Glucuronide Metabolite In Human Plasma And Urine By High-Performance Liquid Chromatography”,Journal of Chromatography B, 2001, pp. 35-45, vol. 763.

Affiliated with

Also associated with

Rating

Crystalline mycophenolate sodium does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Crystalline mycophenolate sodium, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline mycophenolate sodium will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4002015